According to the Zhitong Finance App, *ST Kehua (002022.SZ) issued an announcement. Recently, the company received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the China Drug Administration for the “Human Immunodeficiency Virus Antigen Antibody (HIVAg/Ab) Test Kit (chemiluminescence method)”.
It is reported that this product is used to qualitatively test human immunodeficiency virus (HIV1/2) antibodies and HIV-1p24 antigens in human serum or plasma in vitro.